An observational study in Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant and Transient Tachypnea of the Newborn, sponsored by Mayo Clinic. Recruiting at 1 site in United States. Open to participants aged 32 Weeks to 41 Weeks, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-18.
Sponsored by Mayo Clinic · Observational
The purpose of this study is to analyze the gastric fluid aspirated from the stomachs of neonates receiving routine post-delivery care to predict the need for prolonged respiratory support (>6 hours of life).
The source of the gastric aspirates will be the medical waste generated through the routine care of neonates whose deliveries are attended by the Mayo Clinic neonatal resuscitation team.
123 studies on the registry are indexed under Respiratory Distress Syndrome, Newborn; 24 are open to participants now.
This study's planned enrollment of 500 is above the median of 150 across 25 observational studies indexed under Respiratory Distress Syndrome, Newborn.
Browse Respiratory Distress Syndrome, Newborn studies →Mayo Clinic is the lead sponsor of 3,269 studies on the registry; 672 are open to participants now.
Of its 452 completed or terminated interventional studies of FDA-regulated products, 321 (71%) have results posted.
Counted across the registry records on this site, refreshed daily.
Neonates whose deliveries are attended by the Mayo Clinic neonatal resuscitation team.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Both of the following:
Exclusion Criteria:
Any one of the following:
Performance of the algorithmic prediction of the need for prolonged respiratory support, defined as >6 hours of life.
Calculated sensitivity, specificity, positive- and negative-predictive values of the predicted outcomes compared to actual patient outcomes.
Time frame: 1 years
Accuracy of algorithmic prediction of negative cases of Respiratory Distress Syndrome
Total proportion of true negatives as determined by the digital point-of-care device algorithm predicting no diagnosis of Respiratory Distress Syndrome and the clinician does not diagnosis Respiratory Distress Syndrome. Reported as a calculation of # true negatives / (# true negatives + # false negatives).
Time frame: 2 years
Plan to share: No
Started Mar 2026 (actual). Primary completion is estimated for Oct 2026, 7 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Distress Syndrome, Newborn →